HHS proposes ending safe-harbor for biopharma-pharmacy benefit manager rebates


HHS proposes ending safe-harbor for biopharma-pharmacy benefit manager rebates

The proposed rule, which will be officially published on Wednesday, is part of the Trump administration’s blueprint for reducing out-of-pocket drug prices. However, others have said it could raise premiums and have doubted how much power the administration truly has.



Source: http://bit.ly/2DQhGtj

Post a Comment

0 Comments